---
schema_version: "secwatch.filing_event.v1"
accession: "0001437402-26-000021"
form_type: "8-K"
ticker: "ARDX"
cik: "0001437402"
company_name: "ARDELYX, INC."
filed_at: "2026-04-30T23:59:59+00:00"
generated_at: "2026-05-15T00:39:10.500122+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ardelyx Q1 revenue $93.4M (+38% YoY); IBSRELA revenue $70.1M (+58% YoY)

## Summary
- Net loss $37.6M ($0.15/sh) vs $41.1M ($0.17/sh) Q1 2025; share-based comp $14.2M.
- Cash & investments $238.1M as of Mar 31, 2026; reiterated FY 2026 IBSRELA guidance $410-430M.
- IBSRELA Phase 3 CIC trial (ACCEL) enrolling; topline data expected H2 2027.
- Appointed Rajani Dinavahi, M.D. as CMO and Felecia Ettenberg, Esq. as CLO in April.
- Refinanced debt with SLR Investment Corp for better terms; Morgan Stanley advised.

## SEC filing metadata
- accession: 0001437402-26-000021
- form_type: 8-K
- ticker: ARDX
- cik: 0001437402
- company_name: ARDELYX, INC.
- filed_at: 2026-04-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1437402/000143740226000021/0001437402-26-000021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1437402/000143740226000021/ardx-20260430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437402-26-000021
- JSON: https://secwatch.observer/filing/0001437402-26-000021.json
- Plain text: https://secwatch.observer/filing/0001437402-26-000021.txt

## Key facts
- Earnings Releases
  ARDELYX, INC. reported quarter ended March 31, 2026 results: revenue Total product revenue for the quarter ended March 31, 2026 was $93.4 million, net income Net loss for the quarter ended March 31, 2026 was $37.6 million, EPS $(0.15) per share.
  - Period: quarter ended March 31, 2026
  - Revenue: Total product revenue for the quarter ended March 31, 2026 was $93.4 million
  - Net income: Net loss for the quarter ended March 31, 2026 was $37.6 million
  - EPS: $(0.15) per share
  - Result: reported results
  source text: Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update Q1 2026 total product revenue of $93.4 million, reflecting 38% growth year-over-year
  evidence_url: https://www.sec.gov/Archives/edgar/data/1437402/000143740226000021/0001437402-26-000021-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.